tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT

Adaptive Biotechnologies (ADPT) Financial Statements

813 Followers

Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.483; its P/E ratio is -2.43; Adaptive Biotechnologies is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 41.87M$ 45.78M$ 37.92M$ 48.93M$ 37.65M
Gross Profit$ 23.82M$ 26.17M$ 18.57M$ 31.02M$ 18.97M
EBIT$ -44.54M$ -15.60M$ -46.67M$ -44.21M$ -54.17M
EBITDA$ -41.97M$ -13.20M$ -43.61M$ -40.47M$ -50.35M
Net Income Common Stockholders$ -47.51M$ -69.44M$ -50.30M$ -47.81M$ -57.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 308.87M$ 346.40M$ 371.13M$ 417.23M$ 440.69M
Total Assets$ 620.32M$ 661.13M$ 717.68M$ 764.52M$ 791.46M
Total Debt$ 228.04M$ 229.43M$ 231.23M$ 103.52M$ 105.78M
Net Debt$ -80.83M$ -116.97M$ -139.90M$ -313.71M$ -334.91M
Total Liabilities$ 345.56M$ 352.86M$ 356.05M$ 368.57M$ 367.51M
Stockholders Equity$ 274.91M$ 308.40M$ 361.73M$ 396.04M$ 424.02M
Cash Flow-
Free Cash Flow$ -39.86M$ -28.23M$ -49.46M$ -27.25M$ -62.08M
Operating Cash Flow$ -38.35M$ -26.93M$ -46.68M$ -23.56M$ -59.15M
Investing Cash Flow$ 44.51M$ 3.21M$ 26.14M$ 37.32M$ 62.98M
Financing Cash Flow$ 44.00K$ 87.00K$ 17.00K$ 1.47M$ 672.00K
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis